Tanner Isaacson

Papers

Total Citations

H-Index

About

Tanner Isaacson is a urologic surgeon and researcher whose work centers on optimizing perioperative care and recovery pathways for patients undergoing major urologic oncology procedures, particularly radical cystectomy. His key contributions focus on enhanced recovery after surgery (ERAS) protocols, with a landmark study demonstrating the benefits of alvimopan—a peripherally acting μ-opioid receptor antagonist—in reducing postoperative ileus and shortening hospital stays following radical cystectomy. This work, published in 2015 and cited 19 times, helped establish alvimopan as a standard component of recovery programs in high-volume centers. Isaacson’s research addresses the critical challenge of reducing complications in a procedure known for its high morbidity, directly improving patient outcomes and length of stay. His findings have informed clinical guidelines and influenced the adoption of multimodal recovery strategies. By bridging pharmacological innovation with practical surgical care, Isaacson has made a tangible impact on the quality of life for bladder cancer patients, advancing the field of urologic oncology through evidence-based perioperative management.